The monoclonal antibody therapies made by Regeneron and Eli Lilly, which the omicron coronavirus variant has essentially rendered useless, are still in high use in 12 states, Kaiser Health News reported Jan. 21.
Read the full post on Becker's Hospital Review - Healthcare News
